23.65
-2.35%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Porton Pharma Solutions
Its shares trade on Shenzhen under the ticker 300363.SZ. It has been listed since 29 January 2014. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.42bn and net income of CN¥96.3m. At that date it held total assets of CN¥8.55bn and shareholders' equity of CN¥5.35bn.
Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. The company is headquartered in Chongqing, Chongqing. The company went IPO on 2014-01-29. The firm is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The firm operates its businesses in Europe, North America, Asia and China, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 29 Jan 2014
- Employees
- 3,782
- Website
- porton.cn ↗
Leadership
Pay as last reported
- Mr. Nianfeng JuChairman of the Board, General Manager, since 2009CN¥1.6m
- Mr. Hui ChenFinance Director, Deputy General ManagerCN¥1.4m
- Mr. Yinchun BaiChief Operating Officer, Senior Deputy General ManagerCN¥1.9m
- Ms. Wei PiDeputy General Manager, Secretary of the BoardCN¥879,100
- Mr. Qi ChenDeputy General ManagerCN¥1.5m
- Mr. Po ZhuDeputy General ManagerCN¥1.0m
- Mr. Guojun CaoDirectorCN¥180,000
- Ms. Lina HuDirectorCN¥180,000
- Ms. Ke LiDirector
- Ms. Ying XueDirectorCN¥180,000
- Mr. Weiqiang YangDirectorCN¥180,000
- Mr. Guohua CaoIndependent DirectorCN¥180,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 66
- Environment
- 83
- Social
- 74
- Governance
- 43
- Direct emissions (scope 1)
- 18,865.22 t
- Energy emissions (scope 2)
- 104,187.24 t
- Women in the workforce
- 36.52112%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Porton Pharma Solutions Ltd offers a comprehensive range of services, including drug discovery, development, manufacturing, and packaging. This diversification enables the company to cater to the needs of various clients in the pharmaceutical industry.
- The company boasts a talented team of scientists and researchers who possess advanced skills and expertise in drug development. This allows Porton Pharma Solutions Ltd to stay at the forefront of innovation and deliver cutting-edge solutions to clients.
- Porton Pharma Solutions Ltd has invested heavily in world-class facilities that are equipped with advanced technologies and strict quality control measures. This infrastructure not only ensures efficient operations but also enhances the company's reputation for delivering high-quality pharmaceutical products.
Weaknesses
- Porton Pharma Solutions Ltd relies on external suppliers for certain raw materials and ingredients required in the drug manufacturing process. Any disruptions or issues faced by these suppliers may have a ripple effect on the company's production capabilities and timelines.
- Although Porton Pharma Solutions Ltd has established itself as a reputable player in the pharmaceutical industry, its presence is mainly focused on specific geographical regions. Expanding into new markets and gaining a foothold globally could be a challenge.
Opportunities
- The growing trend of pharmaceutical companies outsourcing various stages of drug development and manufacturing presents an opportunity for Porton Pharma Solutions Ltd to expand its client base and revenues. The company can position itself as a reliable CDMO partner.
- Technological advancements and breakthroughs in pharmaceutical research provide Porton Pharma Solutions Ltd with opportunities to develop innovative drugs and therapies. This can lead to intellectual property rights, increased market share, and enhanced revenue streams.
Threats
- Porton Pharma Solutions Ltd operates in a highly competitive market where numerous pharmaceutical companies strive to capture market share. This intensifying competition presents a threat to the company in terms of pricing pressure and potential loss of clients.
- The pharmaceutical industry is subject to stringent regulations and compliance requirements to ensure product safety and efficacy. Failure to meet these standards can result in legal consequences, damage the company's reputation, and lead to loss of business.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.